Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor. (Q43784919)
Jump to navigation
Jump to search
scientific article published in February 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor. |
scientific article published in February 1992 |
Statements
Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor (English)
P G Satyaswaroop
R J Zaino
1 February 1992